You are here

Eli Lilly

Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis

Fierce Pharma

Wed, 06/17/20 - 09:57 am

spondyloarthritis

Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial

TheStreet.com

Tue, 06/16/20 - 10:52 am

clinical trials

Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19

Forbes

Mon, 06/15/20 - 10:54 am

clinical trials

ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show

Fierce Pharma

Sun, 06/14/20 - 08:14 pm

Evox’s exosome platform draws Lilly in potential $1.2B CNS deal

BioWorld

Tue, 06/9/20 - 11:09 am

Evox Therapeutics

Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials

Fierce Biotech

Mon, 06/8/20 - 11:34 pm

Junshi Biosciences

FDA approval tracker: several early decisions in May

EP Vantage

Wed, 06/3/20 - 10:24 am

Blueprint Medicines

Bristol-Myers Squibb

Marketing Lilly's Cyramza, after split decision from FDA advisers, wins first-line lung cancer nod

Fierce Pharma

Mon, 06/1/20 - 11:34 pm

non-small cell lung cancer

Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis

Fierce Pharma

Mon, 06/1/20 - 11:32 pm

axial spondyloarthritis

Eli Lilly begins first human tests of an antibody drug against Covid-19

Stat

Mon, 06/1/20 - 10:23 am

clinical trials

Lilly wins first-ever FDA approval for drug that can spot Alzheimer's 'tau tangles'

BioPharma Dive

Fri, 05/29/20 - 12:17 pm

Alzheimer's disease

The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round

Fierce Biotech

Wed, 05/27/20 - 10:55 am

A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind

Endpoints

Sun, 05/10/20 - 09:30 pm

Blueprint Medicines

COVID-19: Lilly ramps up to beat the virus with neutralizing antibodies as scientists raise worries

Fierce Biotech

Thu, 05/7/20 - 10:39 am

Junshi Biosciences

Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease

Pharmaceutical Business Review

Tue, 05/5/20 - 10:42 am

Junshi Biosciences

Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year

MedCity News

Mon, 05/4/20 - 10:37 pm

Gilead Sciences

The top pharma companies in social media

Fierce Pharma

Mon, 05/4/20 - 11:02 am

Boehringer Ingelheim

Lilly-partnered AbCellera gets COVID-19 boost from Canadian government

Fierce Biotech

Mon, 05/4/20 - 10:56 am

AbCellera and Lilly Slash Antibody Selection Time for COVID-19 With AI/Machine Learning

BioSpace

Tue, 04/28/20 - 11:43 pm

artificial intelligence

machine learning

AbbVie, Lilly and Gilead stay on top of pharma ad spending list for March amid steady overall spending

Fierce Pharma

Mon, 04/27/20 - 09:21 am

Gilead Sciences

pharma advertising

Pages